Regulatory Updates-September 2020
FDA: Information about Nitrosamine Impurities in Medications Read More.. WHO: Corticosteroids for Covid-19 Read More.. MHRA post-transition period information –
Category: Regulatory Updates
Regulatory Updates-August 2020
FDA: Purple Book, lists of licensed biological products with reference product exclusivity and bio similarity or interchangeability evaluations Read More…
Regulatory Updates-July 2020
EMA: Questions and answers on regulatory expectations for medicinal products for human use during the covid-19 pandemic Read More… Swiss
Regulatory Updates – June 2020
CDSCO: Amendment in export policy for Paracetamol Read More… Philippines FDA: Interim guidelines for the importation and manufacture of personal
Regulatory Updates-May 2020
EMA starts rolling review of remdesivir for COVID-19 Read More… EMA: CHMP recommended the suspension of all ranitidine medicines in the